Zhejiang Gongdong Medical Technology (SH:605369) Zheng Quan Shi Bao Wang·2026-01-23 08:16Core Viewpoint - Gongdong Medical (605369) expects a significant decline in net profit for 2025, projecting a range of 44 million to 56 million yuan, which represents a year-on-year decrease of 67.37% to 74.36% [1] Group 1: Financial Performance - The company anticipates a net profit attributable to the parent company of 44 million to 56 million yuan for 2025 [1] - This projected profit decline is attributed to various factors, including international trade policies and fluctuations in shipping costs affecting the performance of its subsidiary, Trademark Plastics Inc. (TPI) [1] Group 2: Market Conditions - The company is facing challenges due to the impact of U.S. tariff policies and domestic medical "group purchasing" policies, which have led to a slowdown in demand growth for some of its products [1]